Management and Treatment

General Measures and IPAC according to Unit

Clinical Management

  • Seasonal influenza rates are now very low

    • Oseltamivir is not recommended for COVID-19, as there are no known clinical benefits

  • Pregnant women experience immunologic and physiologic changes which might make them more susceptible to viral respiratory infections, including COVID-19

  • Pregnant women might also be at risk for severe illness, morbidity, or mortality compared to the general population as observed in cases of other related coronavirus infections and other viral respiratory infections, such as influenza, during pregnancy

For up to date information:

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.